Pharmicell (005690.KS) is trading -1.08 percent lower on Monday 26th of October and has a trading volume of KRW 4.6 bn
Pharmicell’s stem‑cell drugs face a 24‑hour dip; investors see a 17% drop month‑to‑date and a KRW 13,890 200‑day average as Cellgram‑AMI and other candidates vie for market share.
- PHARMICELL CO LTD
- Korea, Republic Of
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read